CLEARBRIDGE VARIABLE SMALL CAP GROWTH PORTFOLIO
Schedule of investments (unaudited) | September 30, 2022 | |
(Percentages shown based on Portfolio net assets) |
SECURITY | SHARES | VALUE | ||||||
COMMON STOCKS - 96.5% | ||||||||
COMMUNICATION SERVICES - 2.1% | ||||||||
Diversified Telecommunication Services - 1.8% | ||||||||
Iridium Communications Inc. | 142,804 | $ | 6,336,214 | * | ||||
|
| |||||||
Media - 0.3% | ||||||||
Klaviyo Inc. | 69,558 | 1,060,159 | *(a)(b)(c) | |||||
|
| |||||||
TOTAL COMMUNICATION SERVICES | 7,396,373 | |||||||
|
| |||||||
CONSUMER DISCRETIONARY - 8.2% | ||||||||
Auto Components - 2.2% | ||||||||
Fox Factory Holding Corp. | 99,939 | 7,903,176 | * | |||||
|
| |||||||
Diversified Consumer Services - 0.9% | ||||||||
Chegg Inc. | 161,233 | 3,397,180 | * | |||||
|
| |||||||
Hotels, Restaurants & Leisure - 1.6% | ||||||||
Dutch Bros Inc., Class A Shares | 38,205 | 1,190,086 | * | |||||
Sweetgreen Inc., Class A Shares | 19,222 | 355,607 | * | |||||
Wingstop Inc. | 35,100 | 4,402,242 | ||||||
|
| |||||||
Total Hotels, Restaurants & Leisure | 5,947,935 | |||||||
|
| |||||||
Internet & Direct Marketing Retail - 1.2% | ||||||||
Xometry Inc., Class A Shares | 73,600 | 4,179,744 | * | |||||
|
| |||||||
Specialty Retail - 2.3% | ||||||||
National Vision Holdings Inc. | 248,642 | 8,118,161 | * | |||||
|
| |||||||
TOTAL CONSUMER DISCRETIONARY | 29,546,196 | |||||||
|
| |||||||
CONSUMER STAPLES - 9.9% | ||||||||
Food & Staples Retailing - 8.9% | ||||||||
BJ’s Wholesale Club Holdings Inc. | 214,783 | 15,638,350 | * | |||||
Casey’s General Stores Inc. | 41,973 | 8,500,372 | ||||||
Grocery Outlet Holding Corp. | 156,785 | 5,219,373 | * | |||||
Performance Food Group Co. | 59,537 | 2,557,114 | * | |||||
|
| |||||||
Total Food & Staples Retailing | 31,915,209 | |||||||
|
| |||||||
Food Products - 1.0% | ||||||||
Calavo Growers Inc. | 46,100 | 1,463,675 | ||||||
Hain Celestial Group Inc. | 130,681 | 2,205,895 | * | |||||
|
| |||||||
Total Food Products | 3,669,570 | |||||||
|
| |||||||
TOTAL CONSUMER STAPLES | 35,584,779 | |||||||
|
| |||||||
ENERGY - 3.0% | ||||||||
Energy Equipment & Services - 2.5% | ||||||||
Cactus Inc., Class A Shares | 148,480 | 5,706,086 | ||||||
ChampionX Corp. | 177,821 | 3,479,957 | ||||||
|
| |||||||
Total Energy Equipment & Services | 9,186,043 | |||||||
|
|
See Notes to Schedule of Investments.
ClearBridge Variable Small Cap Growth Portfolio 2022 Quarterly Report |
1 |
CLEARBRIDGE VARIABLE SMALL CAP GROWTH PORTFOLIO
Schedule of investments (unaudited) (cont’d) | September 30, 2022 | |
(Percentages shown based on Portfolio net assets) |
SECURITY | SHARES | VALUE | ||||||
Oil, Gas & Consumable Fuels - 0.5% | ||||||||
Matador Resources Co. | 34,000 | $ | 1,663,280 | |||||
|
| |||||||
TOTAL ENERGY | 10,849,323 | |||||||
|
| |||||||
FINANCIALS - 7.5% | ||||||||
Banks - 1.9% | ||||||||
Western Alliance Bancorp | 104,474 | 6,868,120 | ||||||
|
| |||||||
Capital Markets - 2.7% | ||||||||
Hamilton Lane Inc., Class A Shares | 79,020 | 4,710,382 | ||||||
PJT Partners Inc., Class A Shares | 74,458 | 4,975,284 | ||||||
|
| |||||||
Total Capital Markets | 9,685,666 | |||||||
|
| |||||||
Insurance - 2.9% | ||||||||
American Equity Investment Life Holding Co. | 152,992 | 5,705,072 | ||||||
Trupanion Inc. | 81,274 | 4,830,114 | * | |||||
|
| |||||||
Total Insurance | 10,535,186 | |||||||
|
| |||||||
TOTAL FINANCIALS | 27,088,972 | |||||||
|
| |||||||
HEALTH CARE - 23.4% | ||||||||
Biotechnology - 3.7% | ||||||||
Biohaven Pharmaceutical Holding Co. Ltd. | 60,698 | 9,175,717 | * | |||||
CareDx Inc. | 122,942 | 2,092,473 | * | |||||
Ultragenyx Pharmaceutical Inc. | 49,721 | 2,058,946 | * | |||||
|
| |||||||
Total Biotechnology | 13,327,136 | |||||||
|
| |||||||
Health Care Equipment & Supplies - 8.9% | ||||||||
CryoPort Inc. | 88,325 | 2,151,597 | * | |||||
Figs Inc., Class A Shares | 52,870 | 436,178 | * | |||||
Insulet Corp. | 7,976 | 1,829,694 | * | |||||
Integra LifeSciences Holdings Corp. | 136,617 | 5,787,096 | * | |||||
Omnicell Inc. | 50,336 | 4,380,742 | * | |||||
Penumbra Inc. | 51,744 | 9,810,662 | * | |||||
Silk Road Medical Inc. | 112,233 | 5,050,485 | * | |||||
STAAR Surgical Co. | 38,000 | 2,680,900 | * | |||||
|
| |||||||
Total Health Care Equipment & Supplies | 32,127,354 | |||||||
|
| |||||||
Health Care Providers & Services - 3.4% | ||||||||
Progyny Inc. | 186,690 | 6,918,732 | * | |||||
Surgery Partners Inc. | 228,663 | 5,350,714 | * | |||||
|
| |||||||
Total Health Care Providers & Services | 12,269,446 | |||||||
|
| |||||||
Health Care Technology - 0.9% | ||||||||
Certara Inc. | 232,110 | 3,082,421 | * | |||||
|
| |||||||
Life Sciences Tools & Services - 4.8% | ||||||||
Azenta Inc. | 69,783 | 2,990,899 | ||||||
ICON PLC | 34,255 | 6,295,384 | * | |||||
Olink Holding AB, ADR | 107,410 | 1,303,957 | * |
See Notes to Schedule of Investments.
2 | ClearBridge Variable Small Cap Growth Portfolio 2022 Quarterly Report |
CLEARBRIDGE VARIABLE SMALL CAP GROWTH PORTFOLIO
Schedule of investments (unaudited) (cont’d) | September 30, 2022 | |
(Percentages shown based on Portfolio net assets) |
SECURITY | SHARES | VALUE | ||||||
Life Sciences Tools & Services - (continued) | ||||||||
Quanterix Corp. | 27,335 | $ | 301,232 | * | ||||
Syneos Health Inc. | 132,919 | 6,267,131 | * | |||||
|
| |||||||
Total Life Sciences Tools & Services | 17,158,603 | |||||||
|
| |||||||
Pharmaceuticals - 1.7% | ||||||||
Intra-Cellular Therapies Inc. | 33,000 | 1,535,490 | * | |||||
Pacira BioSciences Inc. | 84,252 | 4,481,364 | * | |||||
|
| |||||||
Total Pharmaceuticals | 6,016,854 | |||||||
|
| |||||||
TOTAL HEALTH CARE | 83,981,814 | |||||||
|
| |||||||
INDUSTRIALS - 16.9% | ||||||||
Aerospace & Defense - 0.6% | ||||||||
Aerojet Rocketdyne Holdings Inc. | 54,900 | 2,195,451 | * | |||||
|
| |||||||
Air Freight & Logistics - 2.8% | ||||||||
Forward Air Corp. | 81,712 | 7,375,325 | ||||||
GXO Logistics Inc. | 73,480 | 2,576,209 | * | |||||
|
| |||||||
Total Air Freight & Logistics | 9,951,534 | |||||||
|
| |||||||
Building Products - 3.8% | ||||||||
Hayward Holdings Inc. | 197,620 | 1,752,890 | * | |||||
Masonite International Corp. | 61,090 | 4,355,106 | * | |||||
Trex Co. Inc. | 172,527 | 7,580,836 | * | |||||
|
| |||||||
Total Building Products | 13,688,832 | |||||||
|
| |||||||
Electrical Equipment - 2.8% | ||||||||
Bloom Energy Corp., Class A Shares | 278,069 | 5,558,599 | * | |||||
Shoals Technologies Group Inc., Class A Shares | 204,180 | 4,400,079 | * | |||||
|
| |||||||
Total Electrical Equipment | 9,958,678 | |||||||
|
| |||||||
Machinery - 4.8% | ||||||||
Albany International Corp., Class A Shares | 39,780 | 3,135,858 | ||||||
RBC Bearings Inc. | 52,436 | 10,896,725 | * | |||||
Tennant Co. | 60,097 | 3,399,086 | ||||||
|
| |||||||
Total Machinery | 17,431,669 | |||||||
|
| |||||||
Road & Rail - 0.9% | ||||||||
XPO Logistics Inc. | 73,480 | 3,271,330 | * | |||||
|
| |||||||
Trading Companies & Distributors - 1.2% | ||||||||
H&E Equipment Services Inc. | 146,922 | 4,163,769 | ||||||
|
| |||||||
TOTAL INDUSTRIALS | 60,661,263 | |||||||
|
| |||||||
INFORMATION TECHNOLOGY - 24.2% | ||||||||
Communications Equipment - 0.9% | ||||||||
Viavi Solutions Inc. | 257,278 | 3,357,478 | * | |||||
|
|
See Notes to Schedule of Investments.
ClearBridge Variable Small Cap Growth Portfolio 2022 Quarterly Report |
3 |
CLEARBRIDGE VARIABLE SMALL CAP GROWTH PORTFOLIO
Schedule of investments (unaudited) (cont’d) | September 30, 2022 | |
(Percentages shown based on Portfolio net assets) |
SECURITY | SHARES | VALUE | ||||||
Electronic Equipment, Instruments & Components - 0.9% | ||||||||
Brain Corp. | 52,367 | $ | 192,395 | *(a)(b)(c) | ||||
nLight Inc. | 82,680 | 781,326 | * | |||||
OSI Systems Inc. | 29,643 | 2,136,075 | * | |||||
|
| |||||||
Total Electronic Equipment, Instruments & Components | 3,109,796 | |||||||
|
| |||||||
IT Services - 2.1% | ||||||||
Shift4 Payments Inc., Class A Shares | 113,925 | 5,082,194 | * | |||||
Wix.com Ltd. | 28,540 | 2,232,684 | * | |||||
|
| |||||||
Total IT Services | 7,314,878 | |||||||
|
| |||||||
Semiconductors & Semiconductor Equipment - 5.0% | ||||||||
Allegro MicroSystems Inc. | 253,115 | 5,530,563 | * | |||||
Lattice Semiconductor Corp. | 136,750 | 6,729,468 | * | |||||
Monolithic Power Systems Inc. | 15,791 | 5,738,449 | ||||||
|
| |||||||
Total Semiconductors & Semiconductor Equipment | 17,998,480 | |||||||
|
| |||||||
Software - 15.3% | ||||||||
Aspen Technology Inc. | 24,688 | 5,880,681 | * | |||||
Envestnet Inc. | 86,374 | 3,835,006 | * | |||||
Jamf Holding Corp. | 136,295 | 3,020,297 | * | |||||
Model N Inc. | 171,185 | 5,859,662 | * | |||||
New Relic Inc. | 69,018 | 3,960,253 | * | |||||
PagerDuty Inc. | 264,310 | 6,097,632 | * | |||||
Paycor HCM Inc. | 234,600 | 6,934,776 | * | |||||
Qualys Inc. | 25,565 | 3,563,505 | * | |||||
SEMrush Holdings Inc., Class A Shares | 115,060 | 1,289,823 | * | |||||
Smartsheet Inc., Class A Shares | 52,560 | 1,805,962 | * | |||||
Sprout Social Inc., Class A Shares | 85,120 | 5,165,081 | * | |||||
Varonis Systems Inc. | 217,767 | 5,775,181 | * | |||||
Viant Technology Inc., Class A Shares | 82,905 | 349,030 | * | |||||
Zeta Global Holdings Corp., Class A Shares | 217,670 | 1,438,799 | * | |||||
|
| |||||||
Total Software | 54,975,688 | |||||||
|
| |||||||
TOTAL INFORMATION TECHNOLOGY | 86,756,320 | |||||||
|
| |||||||
MATERIALS - 1.3% | ||||||||
Chemicals - 1.3% | ||||||||
Balchem Corp. | 37,356 | 4,541,742 | ||||||
|
| |||||||
TOTAL COMMON STOCKS (Cost - $258,972,104) | 346,406,782 | |||||||
|
|
See Notes to Schedule of Investments.
4 | ClearBridge Variable Small Cap Growth Portfolio 2022 Quarterly Report |
CLEARBRIDGE VARIABLE SMALL CAP GROWTH PORTFOLIO
Schedule of investments (unaudited) (cont’d) | September 30, 2022 | |
(Percentages shown based on Portfolio net assets) |
SECURITY | RATE | SHARES | VALUE | |||||||||
PREFERRED STOCKS - 0.3% | ||||||||||||
HEALTH CARE - 0.1% | ||||||||||||
Pharmaceuticals - 0.1% | ||||||||||||
Caris Life Sciences Inc., Series C | — | 183,481 | $ | 363,467 | *(a)(b)(c) | |||||||
Caris Life Sciences Inc., Series D | — | 31,383 | 62,168 | *(a)(b)(c) | ||||||||
|
| |||||||||||
TOTAL HEALTH CARE | 425,635 | |||||||||||
|
| |||||||||||
INFORMATION TECHNOLOGY - 0.2% | ||||||||||||
Electronic Equipment, Instruments & Components - 0.2% | ||||||||||||
Brain Corp. | — | 170,237 | 625,447 | *(a)(b)(c) | ||||||||
|
| |||||||||||
TOTAL PREFERRED STOCKS | 1,051,082 | |||||||||||
|
| |||||||||||
TOTAL INVESTMENTS BEFORE SHORT-TERM INVESTMENTS | 347,457,864 | |||||||||||
|
| |||||||||||
SHORT-TERM INVESTMENTS - 3.3% | ||||||||||||
JPMorgan 100% U.S. Treasury Securities Money Market Fund, Institutional Class | 2.482 | % | 9,342,822 | 9,342,822 | ||||||||
Western Asset Premier Institutional U.S. Treasury Reserves, Premium Shares | 2.615 | % | 2,335,706 | 2,335,706 | (d) | |||||||
|
| |||||||||||
TOTAL SHORT-TERM INVESTMENTS | 11,678,528 | |||||||||||
|
| |||||||||||
TOTAL INVESTMENTS - 100.1% | 359,136,392 | |||||||||||
Liabilities in Excess of Other Assets - (0.1)% | (346,402 | ) | ||||||||||
|
| |||||||||||
TOTAL NET ASSETS - 100.0% | $ | 358,789,990 | ||||||||||
|
|
* | Non-income producing security. |
(a) | Security is valued in good faith in accordance with procedures approved by the Board of Trustees (Note 1). |
(b) | Security is valued using significant unobservable inputs (Note 1). |
(c) | Restricted security (Note 3). |
(d) | In this instance, as defined in the Investment Company Act of 1940, an “Affiliated Company” represents Portfolio ownership of at least 5% of the outstanding voting securities of an issuer, or a company which is under common ownership or control with the Portfolio. At September 30, 2022, the total market value of investments in Affiliated Companies was $2,335,706 and the cost was $2,335,706 (Note 2). |
Abbreviation(s) used in this schedule:
ADR | — American Depositary Receipts |
This Schedule of Investments is unaudited and is intended to provide information about the Portfolio’s investments as of the date of the schedule. Other information regarding the Portfolio is available in the Portfolio’s most recent annual or semi-annual shareholder report.
See Notes to Schedule of Investments.
ClearBridge Variable Small Cap Growth Portfolio 2022 Quarterly Report |
5 |
Notes to Schedule of Investments (unaudited)
1. Organization and significant accounting policies
ClearBridge Variable Small Cap Growth Portfolio (the “Portfolio”) is a separate diversified investment series of Legg Mason Partners Variable Equity Trust (the “Trust”). The Trust, a Maryland statutory trust, is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company.
Shares of the Portfolio may only be purchased or redeemed through variable annuity contracts and variable life insurance policies offered by the separate accounts of participating insurance companies or through eligible pension or other qualified plans.
The following are significant accounting policies consistently followed by the Portfolio and are in conformity with U.S. generally accepted accounting principles (“GAAP”).
(a) Investment valuation. Equity securities for which market quotations are available are valued at the last reported sales price or official closing price on the primary market or exchange on which they trade. The valuations for fixed income securities (which may include, but are not limited to, corporate, government, municipal, mortgage-backed, collateralized mortgage obligations and asset-backed securities) and certain derivative instruments are typically the prices supplied by independent third party pricing services, which may use market prices or broker/dealer quotations or a variety of valuation techniques and methodologies. The independent third party pricing services typically use inputs that are observable such as issuer details, interest rates, yield curves, prepayment speeds, credit risks/spreads, default rates and quoted prices for similar securities. Investments in open-end funds are valued at the closing net asset value per share of each fund on the day of valuation. When the Portfolio holds securities or other assets that are denominated in a foreign currency, the Portfolio will normally use the currency exchange rates as of 4:00 p.m. (Eastern Time). If independent third party pricing services are unable to supply prices for a portfolio investment, or if the prices supplied are deemed by the manager to be unreliable, the market price may be determined by the manager using quotations from one or more broker/dealers or at the transaction price if the security has recently been purchased and no value has yet been obtained from a pricing service or pricing broker. When reliable prices are not readily available, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded, but before the Portfolio calculates its net asset value, the Portfolio values these securities as determined in accordance with procedures approved by the Portfolio’s Board of Trustees.
Pursuant to policies adopted by the Board of Trustees, the Portfolio’s manager has been designated as the valuation designee and is responsible for the oversight of the daily valuation process. The Portfolio’s manager is assisted by the Global Fund Valuation Committee (the “Valuation Committee”). The Valuation Committee is responsible for making fair value determinations, evaluating the effectiveness of the Portfolio’s pricing policies, and reporting to the Portfolio’s manager and the Board of Trustees. When determining the reliability of third party pricing information for investments owned by the Portfolio, the Valuation Committee, among other things, conducts due diligence reviews of pricing vendors, monitors the daily change in prices and reviews transactions among market participants.
6 |
Notes to Schedule of Investments (unaudited) (continued)
The Valuation Committee will consider pricing methodologies it deems relevant and appropriate when making fair value determinations. Examples of possible methodologies include, but are not limited to, multiple of earnings; discount from market of a similar freely traded security; discounted cash-flow analysis; book value or a multiple thereof; risk premium/yield analysis; yield to maturity; and/or fundamental investment analysis. The Valuation Committee will also consider factors it deems relevant and appropriate in light of the facts and circumstances. Examples of possible factors include, but are not limited to, the type of security; the issuer’s financial statements; the purchase price of the security; the discount from market value of unrestricted securities of the same class at the time of purchase; analysts’ research and observations from financial institutions; information regarding any transactions or offers with respect to the security; the existence of merger proposals or tender offers affecting the security; the price and extent of public trading in similar securities of the issuer or comparable companies; and the existence of a shelf registration for restricted securities.
For each portfolio security that has been fair valued pursuant to the policies adopted by the Board of Trustees, the fair value price is compared against the last available and next available market quotations. The Valuation Committee reviews the results of such back testing monthly and fair valuation occurrences are reported to the Board of Trustees quarterly.
The Portfolio uses valuation techniques to measure fair value that are consistent with the market approach and/or income approach, depending on the type of security and the particular circumstance. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable securities. The income approach uses valuation techniques to discount estimated future cash flows to present value.
GAAP establishes a disclosure hierarchy that categorizes the inputs to valuation techniques used to value assets and liabilities at measurement date. These inputs are summarized in the three broad levels listed below:
• | Level 1 – unadjusted quoted prices in active markets for identical investments |
• | Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.) |
• | Level 3 – significant unobservable inputs (including the Portfolio’s own assumptions in determining the fair value of investments) |
The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.
7 |
Notes to Schedule of Investments (unaudited) (continued)
The following is a summary of the inputs used in valuing the Portfolio’s assets carried at fair value:
ASSETS | ||||||||||||||||
DESCRIPTION | QUOTED PRICES (LEVEL 1) | OTHER SIGNIFICANT OBSERVABLE INPUTS (LEVEL 2) | SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | TOTAL | ||||||||||||
Long-Term Investments†: | ||||||||||||||||
Common Stocks: | ||||||||||||||||
Communication Services | $ | 6,336,214 | — | $ | 1,060,159 | $ | 7,396,373 | |||||||||
Information Technology | 86,563,925 | — | 192,395 | 86,756,320 | ||||||||||||
Other Common Stocks | 252,254,089 | — | — | 252,254,089 | ||||||||||||
Preferred Stocks: | ||||||||||||||||
Health Care | — | — | 425,635 | 425,635 | ||||||||||||
Information Technology | — | — | 625,447 | 625,447 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total Long-Term Investments | 345,154,228 | — | 2,303,636 | 347,457,864 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Short-Term Investments† | 11,678,528 | — | — | 11,678,528 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total Investments | $ | 356,832,756 | — | $ | 2,303,636 | $ | 359,136,392 | |||||||||
|
|
|
|
|
|
|
|
† | See Schedule of Investments for additional detailed categorizations. |
2. Transactions with affiliated company
As defined by the 1940 Act, an affiliated company is one in which the Portfolio owns 5% or more of the outstanding voting securities, or a company which is under common ownership or control with the Portfolio. The following company was considered an affiliated company for all or some portion of the period ended September 30, 2022. The following transactions were effected in such company for the period ended September 30, 2022.
Purchased | Sold | Realized Gain (Loss) | Dividend Income | Net Increase (Decrease) in Unrealized Appreciation (Depreciation) | Affiliate Value at September 30, 2022 | |||||||||||||||||||||||||||||||
Affiliate Value at December 31, 2021 | Cost | Shares | Cost | Shares | ||||||||||||||||||||||||||||||||
Western Asset Premier Institutional U.S. Treasury Reserves, Premium Shares | $ | 666,377 | $ | 10,435,115 | 10,435,115 | $ | 8,765,786 | 8,765,786 | — | $ | 14,915 | — | $ | 2,335,706 |
8 |
Notes to Schedule of Investments (unaudited) (continued)
3. Restricted securities
The following Portfolio investments are restricted as to resale and, in the absence of readily ascertainable market values, are valued in good faith in accordance with procedures approved by the Board of Trustees.
Security | Number of Shares | Acquisition Date | Cost | Fair Value at 9/30/2022 | Value Per Share | Percent of Net Assets | ||||||||||||||||||
Brain Corp., Common Shares | 52,367 | 3/21 | $ | 228,844 | $ | 192,395 | $ | 3.67 | 0.05 | % | ||||||||||||||
Brain Corp., Preferred Shares | 170,237 | 4/20, 11/20 | 898,085 | 625,447 | 3.67 | 0.17 | ||||||||||||||||||
Caris Life Sciences Inc., Series C, Preferred Shares | 183,481 | 10/20 | 506,407 | 363,467 | 1.98 | 0.10 | ||||||||||||||||||
Caris Life Sciences Inc., Series D, Preferred Shares | 31,383 | 5/21 | 254,202 | 62,168 | 1.98 | 0.02 | ||||||||||||||||||
Klaviyo Inc., Common Shares | 69,558 | 5/21 | 2,321,946 | 1,060,159 | 15.24 | 0.30 | ||||||||||||||||||
|
|
|
|
|
| |||||||||||||||||||
$ | 4,209,484 | $ | 2,303,636 | 0.64 | % | |||||||||||||||||||
|
|
|
|
|
|
9 |